AVITHRAPID

AVITHRAPID is a European flagship project co-funded by the European Commission and the Swiss Confederation, dedicated to accelerating antiviral innovation and strengthening Europe’s preparedness for future epidemics and pandemics.

Public Opinion Survey
 | Your voice is essential

Pandemics continue to influence public health, policy, and scientific priorities. To better understand how citizens, professionals, and institutions perceive these challenges - and what they expect from future preparedness efforts - AVITHRAPID is conducting a new international public opinion survey.

We invite researchers, healthcare professionals, policymakers, students, and citizens to participate.
The survey is anonymous, and you may request the final public report.

Learn how science, innovation, and collaboration protect us from future outbreaks.

researchers | innovators | organizations

Find out how to collaborate in antiviral research and development to accelerate the development of next-generation solutions.

Latest News & Events from AVITHRAPID
Allgemein

New deliverable on exploitation of results

Within the scope of AVITHRAPID, the consortium aims to go beyond the traditional dissemination of project results and foster the creation of a precompetitive collaboration area — a shared space where partners and external stakeholders can interact, exchange know-how, and

Read More »
Allgemein

AVITHRAPID introduced at SC25 exhibition

The AVITHRAPID consortium had a great opportunity to present its ambitious objectives and results during the International Conference for High Performance computing, networking, storage, and analysis in St. Louis, US, on November 17th-21st.  SC is an unparalleled mix of thousands

Read More »

Sing up to receive the latest project-related News and opportunities. |

We use cookies to provide you with the best possible experience on our website.